KMT5B and glioblastoma: In order to determine the expression status of KMT5B in GBM, we measured its mRNA levels by means of qRT-PCR in 13 GBM samples, four human GBM cell lines, and 23 non-tumoral control brains (seven corresponding to gray matter and 16 to white matter samples).